These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25322270)

  • 1. Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study.
    Chubb SA; Byrnes E; Manning L; Beilby JP; Ebeling PR; Vasikaran SD; Golledge J; Flicker L; Yeap BB
    J Clin Endocrinol Metab; 2015 Jan; 100(1):90-9. PubMed ID: 25322270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men.
    Yeap BB; Alfonso H; Chubb SA; Gauci R; Byrnes E; Beilby JP; Ebeling PR; Handelsman DJ; Allan CA; Grossmann M; Norman PE; Flicker L
    J Clin Endocrinol Metab; 2015 Jan; 100(1):63-71. PubMed ID: 25365314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of Undercarboxylated Osteocalcin and Serum P1NP Predict Incidence of Myocardial Infarction in Older Men.
    Yeap BB; Alfonso H; Chubb SA; Byrnes E; Beilby JP; Ebeling PR; Allan CA; Schultz C; Hankey GJ; Golledge J; Flicker L; Norman PE
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3934-42. PubMed ID: 26308289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
    Crandall CJ; Vasan S; LaCroix A; LeBoff MS; Cauley JA; Robbins JA; Jackson RD; Bauer DC
    J Bone Miner Res; 2018 Jul; 33(7):1199-1208. PubMed ID: 29923225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z; Jin X; Bian P; Li X; Chen J
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Turnover Markers Including Undercarboxylated Osteocalcin Are Associated With Mortality Risk in Older Men.
    Robertson CL; Ghosh G; Fitzgerald P; Hankey GJ; Levinger I; Golledge J; Almeida OP; Flicker L; Ebeling PR; Yeap BB
    J Bone Miner Res; 2022 Aug; 37(8):1464-1472. PubMed ID: 35689459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population.
    Dai Z; Wang R; Ang LW; Yuan JM; Koh WP
    Bone; 2016 Feb; 83():171-177. PubMed ID: 26555636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference intervals for bone turnover markers in Spanish premenopausal women.
    Guañabens N; Filella X; Monegal A; Gómez-Vaquero C; Bonet M; Buquet D; Casado E; Cerdá D; Erra A; Martinez S; Montalá N; Pitarch C; Kanterewicz E; Sala M; Surís X; Torres F;
    Clin Chem Lab Med; 2016 Feb; 54(2):293-303. PubMed ID: 26088062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
    Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
    Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related reference intervals for bone turnover markers from an Australian reference population.
    Jenkins N; Black M; Paul E; Pasco JA; Kotowicz MA; Schneider HG
    Bone; 2013 Aug; 55(2):271-6. PubMed ID: 23603243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25(OH)D is associated with an altered bone turnover marker response after a hip fracture.
    Stewart CC; O'Hara NN; Orwig D; Hochberg MC; Sprague S; Magaziner J; Slobogean GP
    J Orthop Res; 2019 Mar; 37(3):535-540. PubMed ID: 30578572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of bone turnover markers after elderly hip fracture surgery.
    Li XP; Li XY; Yang MH; Zhu SW; Wu XB; Zhang P
    J Bone Miner Metab; 2021 Mar; 39(2):237-244. PubMed ID: 32876727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men.
    Siru R; Alfonso H; Chubb SAP; Golledge J; Flicker L; Yeap BB
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):93-99. PubMed ID: 29655173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
    Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
    Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone turnover markers reference database in five Southeast Asian countries.
    Lee JK; Khor HM; Chotiyarnwong P; Unnanuntana A; Amphansap T; Li-Yu J; Cating-Cabral MT; Luceño V; Cao N; Tran T; Ang SB; Puvanendran R; Mat S
    Bone; 2024 Oct; 187():117182. PubMed ID: 38945507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
    Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R;
    J Bone Miner Res; 2009 Sep; 24(9):1544-51. PubMed ID: 19338427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of bone turnover markers in healthy premenopausal women.
    Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
    Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.